snb-1 Antibody

Shipped with Ice Packs
In Stock

Description

SNB-1 Protein and Antibody Overview

SNB-1 is a neuronal v-SNARE protein essential for synaptic vesicle fusion and neurotransmitter release . The SNB-1 antibody (designated SB1) was developed to study synaptic architecture and vesicle dynamics. It recognizes an epitope (PRPSNKRLQQ) within the N-terminal cytoplasmic domain (amino acids 1–86) of SNB-1 .

Antibody Development and Validation

  • Immunogen: Mice were immunized with a His₆-tagged SNB-1 fusion protein lacking the transmembrane domain .

  • Hybridoma lines: Three IgG1 clones (2E6, 5D1, 5G1) were generated, with 5D1 (SB1) showing superior specificity and deposited in the Developmental Studies Hybridoma Bank (DSHB) .

  • Specificity:

    • Western blots detect a 16 kDa band in wild-type lysates, shifted to 19 kDa in snb-1(md247) mutants .

    • Immunostaining localizes SNB-1 to synaptic vesicles in the nerve ring, dorsal/ventral nerve cords, and presynaptic terminals .

Synaptic Vesicle Localization

SB1 enables visualization of synaptic vesicle distribution in GABAergic motor neurons. Key findings include:

  • Reduced anterograde vesicle flux in casy-1 mutants, rescued by CASY-1C overexpression .

  • Impaired vesicle mobility after unc-104 RNAi, highlighting UNC-104/KIF1A's role in transport .

Protein Interaction Studies

  • Co-immunoprecipitation: SB1 confirmed SNB-1 interactions with UNC-10 (active zones) and SAD-1 kinase (neuronal polarity) .

  • Colocalization: SNB-1 puncta overlap with presynaptic markers like UNC-10 and SNT-1 .

Mutant Characterization

  • snb-1 mutants (md247, js17, js124) exhibit aldicarb resistance and synaptic transmission deficits .

Table 1: SNB-1 Antibody Characteristics

ParameterSB1 Performance
Target Genesnb-1
Subcellular LocalizationSynaptic vesicles
Western Blot+++ (16 kDa band in WT)
Immunohistochemistry+++ (nerve ring, cords)
EpitopePRPSNKRLQQ (cytoplasmic)

Key Research Findings

  • Neuronal Polarity: SNB-1 interacts with SAD-1 kinase and Neurabin (NAB-1) to restrict axonal fate .

  • Vesicle Transport: CASY-1 C-terminal recruits UNC-104/KIF1A to regulate GABAergic vesicle motility .

  • Synaptic Defects: snb-1 mutants show aberrant vesicle clustering and neurotransmitter release .

Technical Considerations

  • Limitations: SB1 does not recognize the transmembrane domain, limiting use in full-length SNB-1 studies .

  • Alternatives: GFP-tagged SNB-1 (hpIs66) enables live imaging of vesicle dynamics .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (Made-to-order)
Synonyms
snb-1 antibody; T10H9.4 antibody; Synaptobrevin-1 antibody; Synaptobrevin-related protein 1 antibody
Target Names
snb-1
Uniprot No.

Target Background

Function
This antibody targets a protein involved in the targeting and fusion of transport vesicles with their target membranes. It plays a role in neuronal exocytosis during synaptic transmission, likely contributing to cholinergic transmission. This protein is essential for cell viability, coordinated movement, and the proper function of M3 pharynx motor neurons.
Database Links

KEGG: cel:CELE_T10H9.4

STRING: 6239.T10H9.4

UniGene: Cel.5604

Protein Families
Synaptobrevin family
Subcellular Location
Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane; Single-pass type IV membrane protein. Cell membrane. Cell junction, synapse, synaptosome.
Tissue Specificity
Expressed in the nervous system notably the nerve ring, ventral cord and dorsal cord.

Q&A

Basic Research Questions

  • How is the SNB-1 antibody validated for synaptic vesicle localization studies in C. elegans?

    • Methodology:

      • Use immunofluorescence on whole-mount C. elegans preparations. Compare staining patterns in wild-type and snb-1(md247) mutants. A 16 kDa band (wild-type) shifting to 19 kDa in mutants confirms specificity via Western blot .

      • Include controls like pre-immune serum and secondary antibody-only samples to rule out nonspecific binding.

    • Key Data:

      AssayWild-Type SignalMutant SignalCitation
      Western Blot16 kDa band19 kDa (reduced intensity)
      ImmunohistochemistryNerve ring, dorsal/ventral cordsAbsent in mutants
  • What experimental designs optimize SNB-1 antibody use in dual-labeling studies?

    • Recommendations:

      • Pair monoclonal SNB-1 antibody (e.g., SB1, IgG1 isotype ) with polyclonal antibodies targeting other synaptic markers (e.g., UNC-10/RIM for active zones).

      • Use sequential staining with intermediate fixation steps to avoid cross-reactivity.

Advanced Research Questions

  • How do SNB-1 antibody-epitope interactions influence mechanistic studies of synaptic trafficking?

    • Epitope Mapping:

      • The SB1 antibody binds the SNB-1 N-terminal sequence PRPSNKRLQQ . Design truncation mutants to test epitope necessity for vesicle docking.

      • Combine cryo-EM with antibody labeling to visualize SNB-1 spatial organization in synaptic vesicles.

  • How to resolve contradictions in SNB-1 antibody reactivity across model systems?

    • Troubleshooting Framework:

      • Cross-reactivity: Test antibody on heterologous systems (e.g., HEK293 cells expressing SNB-1 homologs ).

      • Post-translational modifications: Treat lysates with phosphatases/kinases to assess phosphorylation-dependent epitope masking .

Methodological Challenges

  • What quantitative approaches improve SNB-1 antibody-based synaptic vesicle density measurements?

    • Advanced Imaging:

      • Apply Airyscan super-resolution microscopy to resolve clustered SNB-1 punctae (<200 nm spacing).

      • Use Fiji/ImageJ macros for automated puncta counting, normalized to axonal length (e.g., Puncta Analyzer plugin).

  • How does SNB-1 antibody performance compare to CRISPR-tagged endogenous SNB-1 reporters?

    • Validation Strategy:

      MetricAntibody-BasedCRISPR Tagging
      Temporal resolutionLimited by fixationReal-time tracking
      Artifact riskEpitope occlusionTag interference
      • Validate findings with both methods in parallel .

Data Interpretation Guidelines

  • False Positives: Confirm SNB-1 knockdown via qPCR before attributing signal loss to antibody failure.

  • Context-Dependent Variability: Account for developmental stage (e.g., L4 vs. adult worms show 2.3-fold signal difference ).

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.